O
Olivia McAuliffe
Researcher at Teagasc
Publications - 131
Citations - 6489
Olivia McAuliffe is an academic researcher from Teagasc. The author has contributed to research in topics: Bacteriophage & Listeria monocytogenes. The author has an hindex of 37, co-authored 118 publications receiving 5535 citations. Previous affiliations of Olivia McAuliffe include North Carolina State University & University College Cork.
Papers
More filters
Journal ArticleDOI
Lantibiotics: structure, biosynthesis and mode of action
TL;DR: Some of the more recent developments in the biochemistry, genetics and mechanism of action of the lantibiotic peptides are outlined.
Journal ArticleDOI
Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM
Eric Altermann,W. Michael Russell,M. Andrea Azcarate-Peril,Rodolphe Barrangou,B. Logan Buck,Olivia McAuliffe,Olivia McAuliffe,Nicole Souther,Alleson Dobson,Tri Duong,Michael Callanan,Michael Callanan,Sonja Lick,Sonja Lick,Alice Hamrick,Raul J. Cano,Todd R. Klaenhammer +16 more
TL;DR: L. acidophilus NCFM is a probiotic bacterium that has been produced commercially since 1972 and the complete genome is 1,993,564 nt and devoid of plasmids as mentioned in this paper.
Journal ArticleDOI
Bacteriophages and Bacterial Plant Diseases.
TL;DR: The progress and challenges for phage-based disease biocontrol in food crops are examined.
Journal ArticleDOI
Phage Therapy in the Food Industry
TL;DR: Bacteriophages (phages) and their derivatives have emerged as novel, viable, and safe options for the prevention, treatment, and/or eradication of these contaminants in a range of foods and food processing environments.
Journal ArticleDOI
Bacteriophages ϕMR299-2 and ϕNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells
Debebe Alemayehu,Debebe Alemayehu,Pat G. Casey,Olivia McAuliffe,Caitriona M. Guinane,Caitriona M. Guinane,James G. Martin,Fergus Shanahan,Aidan Coffey,R. Paul Ross,R. Paul Ross,Colin Hill +11 more
TL;DR: The efficacy of these two phages in killing clinical Pseudomonas isolates in the murine lung or as a biofilm on a pulmonary cell line is demonstrated and supports the growing interest in using phage therapy for the control and treatment of multidrug-resistant PseUDomonas lung infections in CF patients.